期刊文献+

抗菌药物在腹腔感染中的合理应用 被引量:10

Rational use of antibacterials for intra-abdominal infections
原文传递
导出
摘要 腹腔感染可分为社区获得性腹腔感染及医院获得性腹腔感染。腹腔感染的常见病原菌有肠杆菌科细菌、厌氧菌、链球菌、肠球菌、非发酵糖革兰阴性菌等。抗菌药物的使用是治疗腹腔感染的关键,抗菌药物的使用应结合腹腔感染的具体部位、严重程度、细菌与药物敏感状态的流行病学现状和抗菌药物的药效学和药代动力学特点等因素,选择合理的品种和正确的给药方法。 Summary:Intra-abdominal Infections include community-acquired infection and health care-associated infection. The pathogenic bacteria commonly include Enterobacteriaceae, anaerobic bacteria, Streptococcus, Enterococcus,non-fermented sugar bacteria, etc. Rational antibacterial chemotherapy is very important for intra-abdominal infections. The theraputic regime should follow the principles of right indication, right antibiotics, right time and right method based on the conditions of patients, degree of infection severity, bacterial susceptibility, pharmacody- namics,pharmacokinetics and so on.
作者 叶慧 吕晓菊
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2011年第11期898-900,共3页 Chinese Journal of Practical Internal Medicine
关键词 抗菌药物 腹腔感染 antibacterials intra-abdominal infection
  • 相关文献

参考文献5

二级参考文献10

  • 1Hawser S P,Bouchillon S K,Hoban D J,et al.Emergence of high levels of extended-spectrum-beta-lactamase-producing gram-negative bacilli in the Asia-Pacific region:data from the Study for Monitoring Antimicrobial Resistance Trends(SMART)program,2007[J].Antimicrob Agents Chemother,2009,53(8):3280-3284.
  • 2Wang H,Kelkar S,Wu W,et al.Clinical isolates of Enterobacteriaceae producing extended-spectrum beta-lactamases:prevalence of CTX-M-3 at a hospital in China[J].Antimicrob Agents Chemother,2003,47(2):790-793.
  • 3Montravers P,Lepape A,Dubreuil L,et al.Clinical and microbiological profiles of community-acquired and nosocomial intra-abdominal infections:results of the French prospective,observational EBIIA study[J].J Antimicrob Chemother,2009,63(4):785-794.
  • 4Hsueh PR,Badal RE,Hawser SPet al.Epidemiology and an-timicrobial susceptibility profiles of aerobic and facultativeGram-negative bacilli isolated from patients with intra-abdomi-nal infections in the Asia-Pacific region:2008 results fromSMART(Study for Monitoring Antimicrobial Resistance. International Journal of Antimicrobial Agents . 2010
  • 5Hawser SP,Bouchillon SK,Hoban DJet al.Emergence ofhigh levels of extended-spectrum-beta-lactamase-producinggram-negative bacilli in the Asia-Pacific region:data from theStudy for Monitoring Antimicrobial Resistance Trends(SMART)program,2007. Antimicrobial Agents and Chemotherapy . 2009
  • 6Yang Q,Wang H,Chen M,et al.Surveillance of antimicrobial sus-ceptibility of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in China:the2002-2009Study for Monitoring Antimicrobial Resistance Trends(SMART). International Journal of Antimicrobial Agents . 2010
  • 7王瑶,徐英春,杨启文,谢秀丽,陈民钧.19家医院大肠埃希菌和肺炎克雷伯菌中TEM型β-内酰胺酶的研究[J].临床检验杂志,2008,26(2):85-89. 被引量:31
  • 8王瑶,王澎,徐英春,倪语星,俞云松,胡云建,凌建华,胡必杰,叶惠芬,谢秀丽,张小江,陈民钧.SMART监测腹腔感染患者革兰阴性杆菌体外抗菌药物敏感性研究[J].中国实用内科杂志,2008,28(11):967-970. 被引量:12
  • 9杨启文,王辉,徐英春,曹彬,李宪,胡志东,范红,廖康,褚云卓,曾吉,刘振英,张嵘,徐修礼,王勇,卓超,苏丹虹,周春妹,孙宏莉,谢秀丽,陈民钧.腹腔感染细菌流行病学调查[J].中华普通外科学文献(电子版),2009,3(5):54-57. 被引量:31
  • 10杨启文,王辉,徐英春,陈民钧,曹彬,刘文恩,胡志东,范红,廖康,褚云卓,曾吉,刘振英,张嵘,徐修礼,王勇,卓超,苏丹虹,周春妹,刘颖梅,李宪,田彬,陶传敏,陈冬梅,年华,熊艳,宁永忠,李丽红,杨佩红,李平,谢红梅,孙宏莉,谢秀丽.中国14家教学医院院内菌血症与肺炎和腹腔感染病原菌的抗生素耐药监测[J].中华检验医学杂志,2009,32(12):1367-1375. 被引量:28

共引文献54

同被引文献55

  • 1樊宇荣.感染性休克患者早期目标导向治疗的临床应用[J].实用医学杂志,2009,25(5):733-735. 被引量:7
  • 2周颖杰,李光辉.成人及儿童复杂性腹腔内感染的诊断与处理:美国外科感染学会及美国感染病学会指南[J].中国感染与化疗杂志,2010,10(4):241-247. 被引量:241
  • 3游苏宁.加强导向 势在必行[J].中国实用内科杂志,2006,26(3):321-321. 被引量:2
  • 4余佩武,钱锋.第三型腹膜炎的诊断和治疗[J].腹部外科,2006,19(4):208-210. 被引量:2
  • 5王海燕.肾脏病学[M].3版.北京:人民卫生出版社,2000:1-19.
  • 6任建安.当前腹腔感染诊治的难题与对策[J].中华肠胃外科杂志,2011(07).
  • 7LIU C,BAYER A,COSGROVE SE,et al.Clinical practice guidelines by the infectious diseases society of America in adultsand children[J].Clin Infect Dis,2011,52(3):e18-55.
  • 8刘伟竹,邵隽一.中华医学会杂志社“走基层、转作风、改文风”——倾听一线读者、作者心声座谈会纪要[DB/OL].[2011-12-23].http://www.cma.org.cn/index/qkdt/indexrdxw/20111223/1324607590534-.1.html.
  • 9Kuck NA, Jacobus NV, Petersen PJ, et al. Comparative in vitro andin vivo activities of piperacillin combined with the (3-lactamaseinhibitors tazobactam, clavulanic acid, and sulbactamfj].Antimicrob Agents Chemother, 1989,33(4): 1964-1969.
  • 10Tsuchimochi N, Takuma T, Shimono N, et al. Antinicrobial suscep-tibility and molecular epidemiological analysis of clinical strains ofPseudomonas aeruginosa[J]. J Infect Chem other,2008,14(2):99-104.

引证文献10

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部